Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

GRACEcast Bladder Cancer Video
13/07/2014 7 min
Zykadia for ALK Positive Lung Cancer: New Drug, New Hope

Listen "Zykadia for ALK Positive Lung Cancer: New Drug, New Hope"

Descargar episodio Ver en sitio original

Episode Synopsis

The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.

More episodes of the podcast GRACEcast Bladder Cancer Video

Should Small Cell Lung Cancer Patients Who Respond to Chemo Receive Consolidation Radiotherapy? 31/07/2014
Management of Rare Kidney Tumors 29/07/2014
Should All Small Cell Lung Cancer Patients Receive Prophylactic Cranial Irradiation? 27/07/2014
NanoString Treatment for Kidney Cancer 24/07/2014
Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer? 22/07/2014
How is the Heng Criteria Applied to Kidney Cancer Patients? 20/07/2014
Angiogenesis, the Sequel: Does Cyramza (Ramucirumab) Make a Difference for Second Line Treatment? 17/07/2014
What is PD1 and PDL1 in Kidney Cancer? 15/07/2014
No Clear Answer for Non-Clear Cell Kidney Cancer 10/07/2014
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer 08/07/2014
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA